| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |